OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment
Jingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 5
Jingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 5
Showing 5 citing articles:
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Research progress and perspectives of dual-target inhibitors
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Xiaojing Pang, Wenyan Xu, Jing Liang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117453-117453
Closed Access
Research progress on the antitumor effects of harmine
Yong-hua Hu, Xiaoli Yu, Lei Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Yong-hua Hu, Xiaoli Yu, Lei Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 1
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 1
Synthesis of 6-Aryl-Substituted Derivatives of 8-Acetylharmine and Evaluation of Their Cytotoxicity and Antidepressant Activity
Асел Аманжан, Victor A. Savelyev, O. V. Maslova, et al.
Chemistry of Natural Compounds (2024) Vol. 60, Iss. 6, pp. 1107-1113
Closed Access
Асел Аманжан, Victor A. Savelyev, O. V. Maslova, et al.
Chemistry of Natural Compounds (2024) Vol. 60, Iss. 6, pp. 1107-1113
Closed Access
Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
